4//SEC Filing
Ives Jeffrey L. 4
Accession 0001209191-22-037881
CIK 0001576885other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:25 PM ET
Size
5.3 KB
Accession
0001209191-22-037881
Insider Transaction Report
Form 4
Ives Jeffrey L.
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-15+25,000→ 25,000 totalExercise: $3.59Exp: 2032-06-14→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on on the earlier of June 15, 2023 or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Acumen Pharmaceuticals, Inc.
CIK 0001576885
Entity typeother
Related Parties
1- filerCIK 0001614096
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:25 PM ET
- Size
- 5.3 KB